ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 85 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,701 | -23.4% | 54,745 | -9.1% | 0.00% | – |
| Q2 2023 | $55,719 | +724.5% | 60,237 | +871.6% | 0.00% | – |
| Q1 2023 | $6,758 | -25.3% | 6,200 | 0.0% | 0.00% | – |
| Q4 2022 | $9,052 | +50.9% | 6,200 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -40.0% | 6,200 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -33.3% | 6,200 | -20.5% | 0.00% | – |
| Q1 2022 | $15,000 | -25.0% | 7,796 | +45.7% | 0.00% | – |
| Q4 2021 | $20,000 | -25.9% | 5,351 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -59.7% | 5,351 | -65.9% | 0.00% | – |
| Q2 2021 | $67,000 | +9.8% | 15,670 | +34.3% | 0.00% | – |
| Q1 2021 | $61,000 | +56.4% | 11,671 | +63.0% | 0.00% | – |
| Q4 2020 | $39,000 | +56.0% | 7,161 | +138.6% | 0.00% | – |
| Q3 2020 | $25,000 | +25.0% | 3,001 | +54.2% | 0.00% | – |
| Q2 2020 | $20,000 | +1900.0% | 1,946 | +678.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 250 | -68.8% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 800 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -63.6% | 800 | -60.0% | 0.00% | – |
| Q4 2018 | $11,000 | -71.1% | 2,000 | -28.6% | 0.00% | – |
| Q3 2018 | $38,000 | -22.4% | 2,800 | -33.3% | 0.00% | – |
| Q2 2018 | $49,000 | +28.9% | 4,200 | +23.5% | 0.00% | – |
| Q1 2018 | $38,000 | +216.7% | 3,400 | +78.9% | 0.00% | – |
| Q4 2017 | $12,000 | -25.0% | 1,900 | 0.0% | 0.00% | – |
| Q3 2017 | $16,000 | -50.0% | 1,900 | -73.2% | 0.00% | – |
| Q2 2017 | $32,000 | -23.8% | 7,100 | -6.6% | 0.00% | – |
| Q1 2017 | $42,000 | +600.0% | 7,600 | +442.9% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 1,400 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | +71.4% | 1,400 | +75.0% | 0.00% | – |
| Q1 2016 | $7,000 | 0.0% | 800 | +33.3% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |